Protein-based antigen presentation platforms for nanoparticle vaccines
Abstract Modern vaccine design has sought a minimalization approach, moving to the isolation of antigens from pathogens that invoke a strong neutralizing immune response. This approach has created safer vaccines but may limit vaccine efficacy due to poor immunogenicity. To combat global diseases suc...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-05-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-021-00330-7 |
id |
doaj-48d7babf85fb43848b0cf587c51a6749 |
---|---|
record_format |
Article |
spelling |
doaj-48d7babf85fb43848b0cf587c51a67492021-05-16T11:23:20ZengNature Publishing Groupnpj Vaccines2059-01052021-05-016111110.1038/s41541-021-00330-7Protein-based antigen presentation platforms for nanoparticle vaccinesBrian Nguyen0Niraj H. Tolia1Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institute of HealthLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institute of HealthAbstract Modern vaccine design has sought a minimalization approach, moving to the isolation of antigens from pathogens that invoke a strong neutralizing immune response. This approach has created safer vaccines but may limit vaccine efficacy due to poor immunogenicity. To combat global diseases such as COVID-19, malaria, and AIDS there is a clear urgency for more effective next-generation vaccines. One approach to improve the immunogenicity of vaccines is the use of nanoparticle platforms that present a repetitive array of antigen on its surface. This technology has been shown to improve antigen presenting cell uptake, lymph node trafficking, and B-cell activation through increased avidity and particle size. With a focus on design, we summarize natural platforms, methods of antigen attachment, and advancements in generating self-assembly that have led to new engineered platforms. We further examine critical parameters that will direct the usage and development of more effective platforms.https://doi.org/10.1038/s41541-021-00330-7 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Brian Nguyen Niraj H. Tolia |
spellingShingle |
Brian Nguyen Niraj H. Tolia Protein-based antigen presentation platforms for nanoparticle vaccines npj Vaccines |
author_facet |
Brian Nguyen Niraj H. Tolia |
author_sort |
Brian Nguyen |
title |
Protein-based antigen presentation platforms for nanoparticle vaccines |
title_short |
Protein-based antigen presentation platforms for nanoparticle vaccines |
title_full |
Protein-based antigen presentation platforms for nanoparticle vaccines |
title_fullStr |
Protein-based antigen presentation platforms for nanoparticle vaccines |
title_full_unstemmed |
Protein-based antigen presentation platforms for nanoparticle vaccines |
title_sort |
protein-based antigen presentation platforms for nanoparticle vaccines |
publisher |
Nature Publishing Group |
series |
npj Vaccines |
issn |
2059-0105 |
publishDate |
2021-05-01 |
description |
Abstract Modern vaccine design has sought a minimalization approach, moving to the isolation of antigens from pathogens that invoke a strong neutralizing immune response. This approach has created safer vaccines but may limit vaccine efficacy due to poor immunogenicity. To combat global diseases such as COVID-19, malaria, and AIDS there is a clear urgency for more effective next-generation vaccines. One approach to improve the immunogenicity of vaccines is the use of nanoparticle platforms that present a repetitive array of antigen on its surface. This technology has been shown to improve antigen presenting cell uptake, lymph node trafficking, and B-cell activation through increased avidity and particle size. With a focus on design, we summarize natural platforms, methods of antigen attachment, and advancements in generating self-assembly that have led to new engineered platforms. We further examine critical parameters that will direct the usage and development of more effective platforms. |
url |
https://doi.org/10.1038/s41541-021-00330-7 |
work_keys_str_mv |
AT briannguyen proteinbasedantigenpresentationplatformsfornanoparticlevaccines AT nirajhtolia proteinbasedantigenpresentationplatformsfornanoparticlevaccines |
_version_ |
1721439468424003584 |